Literature DB >> 23303070

Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the δ opioid receptor.

Julie Le Merrer1, Xavier Rezai, Grégory Scherrer, Jérôme A J Becker, Brigitte L Kieffer.   

Abstract

Pharmacological data suggest that delta opioid receptors modulate learning and memory processes. In the present study, we investigated whether inactivation of the delta opioid receptor modifies hippocampus (HPC)- and striatum-dependent behaviors. We first assessed HPC-dependent learning in mice lacking the receptor (Oprd1(-/-) mice) or wild-type (WT) mice treated with the delta opioid antagonist naltrindole using novel object recognition, and a dual-solution cross-maze task. Second, we subjected mutant animals to memory tests addressing striatum-dependent learning using a single-solution response cross-maze task and a motor skill-learning task. Genetic and pharmacological inactivation of delta opioid receptors reduced performance in HPC-dependent object place recognition. Place learning was also altered in Oprd1(-/-) animals, whereas striatum-dependent response and procedural learning were facilitated. Third, we investigated the expression levels for a large set of genes involved in neurotransmission in both HPC and striatum of Oprd1(-/-) mice. Gene expression was modified for several key genes that may contribute to alter hippocampal and striatal functions, and bias striatal output towards striatonigral activity. To test this hypothesis, we finally examined locomotor effects of dopamine receptor agonists. We found that Oprd1(-/-) and naltrindole-treated WT mice were more sensitive to the stimulant locomotor effect of SKF-81297 (D1/D5), supporting the hypothesis of facilitated striatonigral output. These data suggest, for the first time, that delta receptor activity tonically inhibits striatal function, and demonstrate that delta opioid receptors modulate learning and memory performance by regulating the HPC/striatum balance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303070      PMCID: PMC3629400          DOI: 10.1038/npp.2013.1

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  57 in total

1.  Increased ethanol self-administration in delta-opioid receptor knockout mice.

Authors:  A J Roberts; L H Gold; I Polis; J S McDonald; D Filliol; B L Kieffer; G F Koob
Journal:  Alcohol Clin Exp Res       Date:  2001-09       Impact factor: 3.455

2.  Preserved fronto-striatal plasticity and enhanced procedural learning in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe.

Authors:  Silvia Middei; Raffaella Geracitano; Antonio Caprioli; Nicola Mercuri; Martine Ammassari-Teule
Journal:  Learn Mem       Date:  2004 Jul-Aug       Impact factor: 2.460

3.  Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network.

Authors:  Julie Le Merrer; Katia Befort; Olivier Gardon; Dominique Filliol; Emmanuel Darcq; Doulaye Dembele; Jerome A J Becker; Brigitte L Kieffer
Journal:  Addict Biol       Date:  2011-09-28       Impact factor: 4.280

4.  Stimulation of delta1- and delta2-opioid receptors produces amnesia in mice.

Authors:  M Ukai; A Takada; Y Sasaki; T Kameyama
Journal:  Eur J Pharmacol       Date:  1997-10-29       Impact factor: 4.432

5.  Thalamic gating of corticostriatal signaling by cholinergic interneurons.

Authors:  Jun B Ding; Jaime N Guzman; Jayms D Peterson; Joshua A Goldberg; D James Surmeier
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

6.  Mu opioid receptor activation normalizes temporo-ammonic pathway driven inhibition in hippocampal CA1.

Authors:  A Rory McQuiston
Journal:  Neuropharmacology       Date:  2010-11-04       Impact factor: 5.250

7.  Delta opioid receptor ligands modulate anxiety-like behaviors in the rat.

Authors:  Shane A Perrine; Brian A Hoshaw; Ellen M Unterwald
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

8.  Memory retrieval enhancement by kappa opioid agonist and mu, delta antagonists.

Authors:  R Y Ilyutchenok; N I Dubrovina
Journal:  Pharmacol Biochem Behav       Date:  1995-12       Impact factor: 3.533

Review 9.  Exhumed from thought: basal ganglia and response learning in the plus-maze.

Authors:  Mark G Packard
Journal:  Behav Brain Res       Date:  2008-12-14       Impact factor: 3.332

10.  Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum.

Authors:  Emily L Jocoy; Véronique M André; Damian M Cummings; Shilpa P Rao; Nanping Wu; Amy J Ramsey; Marc G Caron; Carlos Cepeda; Michael S Levine
Journal:  Front Syst Neurosci       Date:  2011-05-11
View more
  26 in total

1.  Novel Object Recognition and Object Location Behavioral Testing in Mice on a Budget.

Authors:  Jiyeon K Denninger; Bryon M Smith; Elizabeth D Kirby
Journal:  J Vis Exp       Date:  2018-11-20       Impact factor: 1.355

2.  Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.

Authors:  Aura C Meirsman; Julie Le Merrer; Lucie P Pellissier; Jorge Diaz; Daniel Clesse; Brigitte L Kieffer; Jérôme A J Becker
Journal:  Biol Psychiatry       Date:  2015-06-06       Impact factor: 13.382

Review 3.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 4.  The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Authors:  Paul Klenowski; Michael Morgan; Selena E Bartlett
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 5.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

6.  Comparison of interval timing behaviour in mice following dorsal or ventral hippocampal lesions with mice having δ-opioid receptor gene deletion.

Authors:  Bin Yin; Warren H Meck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-01-20       Impact factor: 6.237

7.  Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity.

Authors:  Jérôme A J Becker; Daniel Clesse; Coralie Spiegelhalter; Yannick Schwab; Julie Le Merrer; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2014-03-12       Impact factor: 7.853

Review 8.  Usefulness of knockout mice to clarify the role of the opioid system in chronic pain.

Authors:  Rafael Maldonado; Josep Eladi Baños; David Cabañero
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

9.  Delta opioid receptor agonists are effective for multiple types of headache disorders.

Authors:  Laura S Moye; Alycia F Tipton; Isaac Dripps; Zoie Sheets; Aimee Crombie; Jonathan D Violin; Amynah A Pradhan
Journal:  Neuropharmacology       Date:  2018-12-14       Impact factor: 5.250

10.  Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol.

Authors:  Jérôme A J Becker; Brigitte L Kieffer; Julie Le Merrer
Journal:  Addict Biol       Date:  2016-04-28       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.